Absolute benefits of aromatase inhibitors in adjuvant treatment of breast cancer: should we know more?
Seruga
Bostjan
B
Ocana
Alberto
A
Niraula
Saroj
S
Amir
Eitan
E
D000970:Antineoplastic Agents / Q000008:administration & dosage* / Q000627:therapeutic use*; D047072:Aromatase Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000401:mortality; D017024:Chemotherapy, Adjuvant; D005260:Female; D006801:Humans; D015201:Meta-Analysis as Topic; D012107:Research Design
D000970:Antineoplastic Agents; D047072:Aromatase Inhibitors